Seres Therapeutics (MCRB) Institutional Ownership $7.50 -0.49 (-6.13%) Closing price 04:00 PM EasternExtended Trading$7.61 +0.11 (+1.48%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Seres Therapeutics (NASDAQ:MCRB)CurrentInstitutional OwnershipPercentage59.34%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$59.61MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$12.67M Get MCRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Seres Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MCRB Institutional Buying and Selling by Quarter Seres Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.74,629$52K0.0%+40.9%0.855% 5/12/2025 Invesco Ltd.136,572$96K0.0%+193.2%1.564% 5/9/2025 Charles Schwab Investment Management Inc.834,107$584K0.0%-3.7%9.568% 5/2/2025 SBI Securities Co. Ltd.69,664$49K0.0%+221.8%0.799% 4/28/2025 Vontobel Holding Ltd.1,085,966$760K0.0%+15.7%12.457% 2/17/2025 Millennium Management LLC1,810,719$1.51M0.0%+77.2%1.061% 2/17/2025 Cantor Fitzgerald L. P.95,740$80K0.0%-65.9%0.056% 2/14/2025 Jane Street Group LLC58,736$49K0.0%+181.4%0.034% 2/14/2025 Schonfeld Strategic Advisors LLC100,700$84K0.0%-76.8%0.059% 2/14/2025 Northern Trust Corp262,683$218K0.0%+20.4%0.154% Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025 Geode Capital Management LLC1,510,432$1.26M0.0%+8.8%0.885% 2/11/2025 LPL Financial LLC94,787$79K0.0%-22.4%0.056% 2/10/2025 Avantax Advisory Services Inc.45,179$38K0.0%+170.9%0.026% 2/6/2025 Charles Schwab Investment Management Inc.865,825$720K0.0%+15.6%0.507% 1/30/2025 Vontobel Holding Ltd.938,295$780K0.0%+137.6%0.550% 1/17/2025 Janney Montgomery Scott LLC48,500$40K0.0%-29.8%0.028% 11/20/2024 Virtu Financial LLC58,791$56K0.0%+44.8%0.034% 11/16/2024 Geode Capital Management LLC1,388,639$1.31M0.0%+22.5%0.816% 11/15/2024 State Street Corp383,248$363K0.0%+12.9%0.225% 11/15/2024 Point72 Asia Singapore Pte. Ltd.44,972$43K0.0%-64.8%0.026% 11/14/2024 Providence Wealth Advisors LLC98,500$93K0.1%+29.2%0.058% 11/13/2024 FMR LLC22,857,260$21.63M0.0%+0.6%13.430% 11/12/2024 Charles Schwab Investment Management Inc.748,718$708K0.0%+42.4%0.440% 10/16/2024 Vontobel Holding Ltd.394,826$374K0.0%N/A0.261% 9/16/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 9/16/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/15/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/14/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 8/9/2024 Providence Wealth Advisors LLC76,250$58K0.0%+49.5%0.050% 8/1/2024 Rhumbline Advisers55,112$40K0.0%-61.0%0.036% 5/20/2024 Virtu Financial LLC94,510$73K0.0%N/A0.062% 5/15/2024 Price T Rowe Associates Inc. MD298,111$232K0.0%-18.0%0.197% 5/10/2024 Vanguard Group Inc.6,734,821$5.21M0.0%+12.1%4.460% 5/1/2024 BNP Paribas Financial Markets46,549$36K0.0%-19.8%0.031% 5/1/2024 Mirae Asset Global Investments Co. Ltd.50,102$39K0.0%N/A0.033% 2/14/2024 Pennant Investors LP292,300$409K0.1%N/A0.226% 2/13/2024 Tower Research Capital LLC TRC38,091$53K0.0%+668.6%0.029% 2/1/2024 Handelsbanken Fonder AB1,100,000$1.54M0.0%+10.0%0.851% 1/24/2024 Clear Creek Financial Management LLC26,950$38K0.0%-47.6%0.021% 1/12/2024 SG Americas Securities LLC52,080$73K0.0%N/A0.040% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.12/7/2023 Hudson Bay Capital Management LP1,999,800$4.76M0.0%+127.3%1.547% 11/22/2023 Graham Capital Management L.P.206,838$492K0.0%+731.3%0.160% 11/14/2023 Corton Capital Inc.23,245$55K0.0%-64.7%0.018% 11/14/2023 Profund Advisors LLC155,798$371K0.0%+11.9%0.121% 11/13/2023 Federated Hermes Inc.8,981,717$21.38M0.1%-21.2%6.949% 11/13/2023 Dark Forest Capital Management LP117,498$280K0.0%N/A0.091% 11/13/2023 Aigen Investment Management LP75,241$179K0.0%+577.1%0.058% 11/13/2023 FMR LLC19,230,692$45.77M0.0%+0.2%14.878% 11/13/2023 Rafferty Asset Management LLC936,382$2.23M0.0%+21.1%0.724% 11/7/2023 Quantbot Technologies LP50,400$120K0.0%N/A0.039% 11/7/2023 Barclays PLC461,209$1.10M0.0%+24.3%0.360% 10/30/2023 Arete Wealth Advisors LLC24,900$59K0.0%+99.2%0.019% 10/23/2023 Commonwealth Equity Services LLC11,040$26K0.0%N/A0.009% 10/19/2023Simplicity Solutions LLC11,294$27K0.0%N/A0.009% 10/11/2023 Vontobel Holding Ltd.17,000$40K0.0%-52.6%0.013% 8/14/2023 Great Point Partners LLC938,067$4.49M0.9%N/A0.732% 8/14/2023 UniSuper Management Pty Ltd415,292$1.99M0.0%N/A0.324% 8/14/2023 Parallax Volatility Advisers L.P.134,901$646K0.0%N/A0.105% 8/14/2023 Graham Capital Management L.P.24,881$119K0.0%N/A0.019% 8/11/2023 Natixis99,000$474K0.0%N/A0.077% 8/11/2023 E Fund Management Co. Ltd.41,581$199K0.0%+206.1%0.032% 8/11/2023 ExodusPoint Capital Management LP594,895$2.85M0.0%N/A0.464% 8/10/2023 Profund Advisors LLC139,249$667K0.0%+210.4%0.109% 8/9/2023 BNP Paribas Arbitrage SNC154,663$741K0.0%+61.9%0.121% 8/7/2023 Principal Financial Group Inc.45,205$217K0.0%+21.5%0.035% 8/4/2023 American International Group Inc.46,820$224K0.0%+37.7%0.037% 8/3/2023 Jennison Associates LLC1,392,356$6.67M0.0%+109.5%1.089% 8/2/2023 Handelsbanken Fonder AB1,000,000$4.79M0.0%+25.0%0.782% 7/31/2023 LPL Financial LLC115,058$551K0.0%+20.3%0.090% 7/31/2023 Alpha DNA Investment Management LLC138,536$664K0.2%N/A0.108% 7/28/2023 Mach 1 Financial Group LLC94,961$455K0.1%N/A0.074% 7/26/2023 Janney Montgomery Scott LLC90,285$432K0.0%-11.7%0.071% 7/25/2023Raymond James & Associates10,052$48K0.0%N/A0.008% 7/24/2023 Vontobel Holding Ltd.35,865$172K0.0%+74.6%0.028% 7/21/2023 Creative Planning17,304$83K0.0%N/A0.014% 7/19/2023 Teacher Retirement System of Texas27,360$131K0.0%-10.9%0.021% 7/18/2023 Diversified Trust Co10,000$48K0.0%N/A0.008% 7/17/2023 Clear Creek Financial Management LLC54,200$260K0.0%N/A0.042% 7/14/2023 Aries Wealth Management18,000$86K0.0%+50.0%0.014% 7/13/2023 Cambridge Investment Research Advisors Inc.44,844$215K0.0%N/A0.035% 7/10/2023 AE Wealth Management LLC95,188$456K0.0%N/A0.074% 7/7/2023 Auour Investments LLC17,000$81K0.0%N/A0.013% 5/16/2023 Avoro Capital Advisors LLC1,295,000$7.34M0.1%N/A1.013% 5/15/2023 Atom Investors LP90,388$512K0.3%-5.4%0.071% 5/12/2023 Profund Advisors LLC44,859$254K0.0%N/A0.035% 5/11/2023 PFG Investments LLC20,500$116K0.0%N/A0.016% 5/11/2023 FMR LLC18,911,458$107.23M0.0%+1.2%14.794% 5/11/2023 Knott David M Jr315,000$1.79M0.7%+57.4%0.246% 5/11/2023 E Fund Management Co. Ltd.13,585$77K0.0%-18.5%0.011% 5/10/2023 Oppenheimer & Co. Inc.37,111$210K0.0%N/A0.029% Elon’s NEXT Big IPO? (Ad)Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.One that experts predict could be worth over $3.2 TRILLION globally by 2030.5/10/2023 Simplify Asset Management Inc.550,626$3.12M0.4%N/A0.431% 5/8/2023 Federated Hermes Inc.15,277,356$86.62M0.2%-15.5%11.951% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank24,010$136K0.0%+39.0%0.019% 5/4/2023 Barclays PLC110,060$624K0.0%-37.7%0.086% 5/4/2023 Mirae Asset Global Investments Co. Ltd.62,240$353K0.0%+16.9%0.049% 5/2/2023 Venturi Wealth Management LLC20,000$113K0.0%N/A0.016% 4/28/2023 SG Americas Securities LLC43,684$248K0.0%+206.6%0.034% 4/28/2023 Janney Montgomery Scott LLC102,281$580K0.0%+5.5%0.080% 4/28/2023 Handelsbanken Fonder AB800,000$4.54M0.0%N/A0.626% 4/26/2023 Jennison Associates LLC664,734$3.77M0.0%-0.6%0.527% (Data available from 1/1/2016 forward) MCRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MCRB shares? During the previous two years, 63 institutional investors and hedge funds held shares of Seres Therapeutics. The most heavily invested institutionals were FMR LLC ($21.63M), Federated Hermes Inc. ($21.38M), Jennison Associates LLC ($6.67M), Vanguard Group Inc. ($5.21M), Hudson Bay Capital Management LP ($4.76M), Great Point Partners LLC ($4.49M), and ExodusPoint Capital Management LP ($2.85M).Learn more on MCRB's institutional investors. What percentage of Seres Therapeutics stock is owned by institutional investors? 59.34% of Seres Therapeutics stock is owned by institutional investors. Learn more on MCRB's institutional investor holdings. Which institutional investors have been buying Seres Therapeutics stock? Of the 54 institutional investors that purchased Seres Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hudson Bay Capital Management LP ($1.12M), Vontobel Holding Ltd. ($1.10M), Great Point Partners LLC ($938.07K), Millennium Management LLC ($788.76K), Vanguard Group Inc. ($729.51K), Jennison Associates LLC ($727.62K), and ExodusPoint Capital Management LP ($594.90K). How much institutional buying is happening at Seres Therapeutics? Institutional investors have bought a total of 10,637,474 shares in the last 24 months. This purchase volume represents approximately $545.96M in transactions. Which Seres Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold Seres Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Federated Hermes Inc. ($2.41M), Schonfeld Strategic Advisors LLC ($333.20K), Cantor Fitzgerald L. P. ($184.83K), Rhumbline Advisers ($86.34K), Point72 Asia Singapore Pte. Ltd. ($82.66K), Price T Rowe Associates Inc. MD ($65.54K), and Corton Capital Inc. ($42.53K). How much institutional selling is happening at Seres Therapeutics? Institutional investors have sold a total of 3,358,134 shares in the last 24 months. This volume of shares sold represents approximately $133.80M in transactions. Related Companies ANNX Institutional Ownership NGNE Institutional Ownership PRTA Institutional Ownership RNAC Institutional Ownership PVLA Institutional Ownership INAB Institutional Ownership CRVS Institutional Ownership AVIR Institutional Ownership IMMP Institutional Ownership TSVT Institutional Ownership This page (NASDAQ:MCRB) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
